4basebio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. 4basebio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 89% to $506,000. Profit margin reached -1515%. Total operating expenses were $8,392,000.

Profit Margin

4basebio PLC (LSE:4BB.L): Profit margin
2019 202K -423K -209.41%
2020 462K -719K -155.63%
2021 338K -3.23M -957.1%
2022 268K -5.15M -1921.64%
2023 506K -7.66M -1514.82%

4BB.L Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
506K268K338K462K202K
Cost of revenue
166K29K69K188K230K
Gross profit
340K239K269K274K-28K
Operating exp.
Research and development
3.56M2.08M1.62M343K241K
Selling and marketing
280K245K132K141K18K
Total operating expenses
8.39M6.07M3.79M896K392K
Operating income
-8.05M-5.84M-3.52M-622K-420K
Other income (expenses), net
-301.99K-89K-113K-94K-109K
Income before tax
-8.35M-5.92M-3.64M-716K-529K
Income tax expense
-689K-779K-405K3K-106K
Net income
-7.66M-5.15M-3.23M-719K-423K
Earnings per share
Basic EPS
-0.62-0.42-0.26-0.05-0.03
Diluted EPS
-0.62-0.42-0.26-0.05-0.03
Data sourceData sourceData sourceData sourceData source